The overlay creates a localized infection environment by restricting movement of progeny virions through the culture medium. As infected cells and nearby cells undergo virus-associated damage, each initially infected focus can develop into a discrete plaque rather than merging into a diffuse pattern. This spatial separation makes visible infection events countable and supports estimation of infectious virus titer.
Agarose or methylcellulose supplies the semisolid character needed for the overlay. The key functional consequence is reduced diffusion of newly produced virions, not elimination of viral replication. Because spread remains localized, plaque boundaries can be visualized after incubation and staining, allowing investigators to relate the overlay condition to the clarity and measurability of infection patterns.
MDCK cells provide the susceptible cell surface on which infection can be initiated and propagated locally. Their monolayer gives plaques a spatial context: cell damage can be associated with neighboring rounds of infection rather than treated as an unlocalized signal. In respiratory-virus experiments, this arrangement connects virus-induced damage with a measurable culture outcome.
An experiment begins with infection of a susceptible MDCK monolayer, followed by addition of the semisolid overlay medium. After incubation, the culture is stained so damaged infection zones become observable, and plaques are counted. Keeping these stages conceptually separate helps distinguish the biological infection process from the later visualization and quantification steps used to calculate infectious titer.
Plaque counts provide an estimate of infectious virus titer, meaning the amount of virus capable of producing measurable infection under the assay conditions. Repeating the same readout across experimental samples allows researchers to compare viral replication, the effect of neutralization, or antiviral activity. The outcome is therefore quantitative rather than merely a visual observation of cell damage.
It is useful when investigators need to connect a treatment or immune effect with a change in infectious virus output. In influenza and other respiratory-virus studies, localized plaques create a common readout for comparing replication, neutralization, and antiviral activity. The assay therefore links infection biology to an observable endpoint that can be counted across experimental conditions.